72 related articles for article (PubMed ID: 1970753)
1. Alteration of differentiation state of human hepatocytes cultured with novobiocin and butyrate.
Kaneko Y; Nakayama T; Tsukamoto A; Kurokawa K
Cancer Res; 1990 May; 50(10):3101-5. PubMed ID: 1970753
[TBL] [Abstract][Full Text] [Related]
2. Increased assembly of cytoskeletal proteins associated with the transformation of human liver cells into fibroblast-like cells.
Tsukamoto A; Kaneko Y; Kurokawa K
Experientia; 1992 May; 48(5):495-7. PubMed ID: 1376281
[TBL] [Abstract][Full Text] [Related]
3. Vacuole formation and cytokeratin rearrangement of hepatoma cells induced by teleocidin are not associated with down-regulation of protein kinase C.
Kaneko Y; Tsukamoto A; Kurokawa K
Cancer Res; 1991 May; 51(10):2677-82. PubMed ID: 1708698
[TBL] [Abstract][Full Text] [Related]
4. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression.
Saito H; Ebinuma H; Takahashi M; Kaneko F; Wakabayashi K; Nakamura M; Ishii H
Hepatology; 1998 May; 27(5):1233-40. PubMed ID: 9581676
[TBL] [Abstract][Full Text] [Related]
5. Novobiocin modulates cytokeratin assembly and differentiation of human hepatoma cells induced by butyrate and teleocidin.
Tsukamoto A; Kaneko Y; Kurokawa K
Cancer Lett; 1991 Oct; 60(1):51-7. PubMed ID: 1717136
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast-like transformation and c-myc gene alteration of human hepatocytes induced by novobiocin and butyrate.
Kaneko Y; Nakayama T; Hamasaki T; Tsukamoto A; Toda G; Oka H
Biochem Biophys Res Commun; 1988 Aug; 155(1):305-10. PubMed ID: 2843181
[TBL] [Abstract][Full Text] [Related]
7. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
Nakamura M; Saito H; Ebinuma H; Wakabayashi K; Saito Y; Takagi T; Nakamoto N; Ishii H
J Cell Physiol; 2001 Jun; 187(3):392-401. PubMed ID: 11319763
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate induces apoptosis in human hepatoma cells by a mitochondria/caspase pathway, associated with degradation of beta-catenin, pRb and Bcl-XL.
Emanuele S; D'Anneo A; Bellavia G; Vassallo B; Lauricella M; De Blasio A; Vento R; Tesoriere G
Eur J Cancer; 2004 Jun; 40(9):1441-52. PubMed ID: 15177505
[TBL] [Abstract][Full Text] [Related]
9. [Effects of sodium butyrate on proliferation of human gastric cancer cells and expression of p16 gene].
Shen WJ; Dai DQ; Teng Y; Liu J
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1192-6. PubMed ID: 18844115
[TBL] [Abstract][Full Text] [Related]
10. Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: evidence for a role of hepatocyte growth factor.
Neaud V; Faouzi S; Guirouilh J; Le Bail B; Balabaud C; Bioulac-Sage P; Rosenbaum J
Hepatology; 1997 Dec; 26(6):1458-66. PubMed ID: 9397985
[TBL] [Abstract][Full Text] [Related]
11. Ligand-independent activation of the androgen receptor by the differentiation agent butyrate in human prostate cancer cells.
Sadar MD; Gleave ME
Cancer Res; 2000 Oct; 60(20):5825-31. PubMed ID: 11059779
[TBL] [Abstract][Full Text] [Related]
12. [Molecular and cellular action of butyrate].
Kruh J; Defer N; Tichonicky L
C R Seances Soc Biol Fil; 1992; 186(1-2):12-25. PubMed ID: 1450986
[TBL] [Abstract][Full Text] [Related]
13. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
14. GATA-1 is essential in EGF-mediated induction of nucleotide excision repair activity and ERCC1 expression through ERK2 in human hepatoma cells.
Andrieux LO; Fautrel A; Bessard A; Guillouzo A; Baffet G; Langouët S
Cancer Res; 2007 Mar; 67(5):2114-23. PubMed ID: 17332341
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of proliferation, invasion and adhesion of liver cancer cells by 5-azacytidine and butyrate.
Wang XM; Li J; Evers BM
Anticancer Res; 1999; 19(4B):2901-6. PubMed ID: 10652571
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle gene regulation in reversibly differentiated new human hepatoma cell lines.
Glaise D; Ilyin GP; Loyer P; Cariou S; Bilodeau M; Lucas J; Puisieux A; Ozturk M; Guguen-Guillouzo C
Cell Growth Differ; 1998 Feb; 9(2):165-76. PubMed ID: 9486853
[TBL] [Abstract][Full Text] [Related]
17. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture.
Niki T; Rombouts K; De Bleser P; De Smet K; Rogiers V; Schuppan D; Yoshida M; Gabbiani G; Geerts A
Hepatology; 1999 Mar; 29(3):858-67. PubMed ID: 10051490
[TBL] [Abstract][Full Text] [Related]
18. Induction of senescent cell-derived inhibitor of DNA synthesis gene, SDI1, in hepatoblastoma (HepG2) cells arrested in the G2-phase of the cell cycle by 9-nitrocamptothecin.
Khaoustov VI; Ozer A; Smith JR; Noda A; Mearns M; Krishnan B; Slagle BL; Yoffe B
Lab Invest; 1995 Jul; 73(1):118-27. PubMed ID: 7603034
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells.
Foss FM; Veillette A; Sartor O; Rosen N; Bolen JB
Oncogene Res; 1989; 5(1):13-23. PubMed ID: 2476706
[TBL] [Abstract][Full Text] [Related]
20. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
